Can a telemedicine program help people with HIV and addiction get better care?

NCT ID NCT06370481

Recruiting now Knowledge-focused Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether telemedicine can help people living with HIV in Alabama who also struggle with opioid or stimulant misuse get follow-up care. Thirty participants will receive either telemedicine or standard care. The goal is to see if telemedicine is feasible and acceptable, not to measure health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: telemedicine
What this could lead to: If successful, this could show that telemedicine is a practical way to deliver addiction care alongside HIV treatment, improving access for underserved populations.
What could go wrong: This is a small pilot study with only 30 participants, so results may not apply broadly. It tests feasibility, not effectiveness, so it won't prove whether telemedicine improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS disease HIV infectious disease opiate dependence substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV OPIOID-USE DISORDER STIMULANT USE (DIAGNOSIS) SUBSTANCE USE DISORDERS

Contacts and locations

Locations

University of Alabama at Birmingham
RECRUITING

Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.